1. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

   • Christoph J. Rageth
   • Elizabeth AM O’Flynn
   • Zsuzsanna Varga

   Review Open access 13 August 2016 Pages: 203 - 213

2. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis

   • Mohammad A. Aleskandarany
   • Rezvan Abduljabbar
   • Emad A. Rakha

   Preclinical study 11 August 2016 Pages: 215 - 227

   

3. Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes

   • Sue Zann Lim
   • Sathiyamoorthy Selvarajan
   • Puay Hoon Tan

   Preclinical study 19 August 2016 Pages: 229 - 244

   

4. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity

   • Pedro Pinto
   • Paula Paulo
   • Manuel R. Teixeira

   Preclinical study 23 August 2016 Pages: 245 - 256

   

5. St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods

   • Cornelia M. Focke
   • Paul J. van Diest
   • Thomas Decker

   Preclinical study 24 August 2016 Pages: 257 - 263

   

6. Clinical significance of noncalcified lung nodules in patients with breast cancer

   • Feng Li
   • Samuel G. Armato
   • Heber MacMahon

   Clinical trial 09 August 2016 Pages: 265 - 271

   

7. Impact of clinical trial on survival outcomes

   • Fanny Le Du
   • Takeo Fujii
   • Naoto T. Ueno

   Clinical trial 16 August 2016 Pages: 273 - 281

   

8. Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial

   • Laura Q. Rogers
   • Kerry S. Courneya
   • Edward McAuley

   Clinical trial 18 August 2016 Pages: 283 - 291

   

9. Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study

   • Antonis Valachis
   • Hans Garmo
   • Lars Holmberg

   Epidemiology Open access 05 August 2016 Pages: 293 - 303

   

10. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study

    • Deependra Singh
    • Janne Pitkäniemi
    • Ahti Anttila

    Epidemiology Open access 05 August 2016 Pages: 305 - 313

    

11. 21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013

    • Benjamin M. Parsons
    • Jeffrey Landercasper
    • Leah L. Dietrich

    Epidemiology Open access 09 August 2016 Pages: 315 - 326

    

12. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk

    • Ting Bao
    • Coby Basal
    • Jun J. Mao

    Epidemiology 10 August 2016 Pages: 327 - 333

    

13. Lifetime grain consumption and breast cancer risk

    • Maryam S. Farvid
    • Eunyoung Cho
    • Walter C. Willett

    Epidemiology 10 August 2016 Pages: 335 - 345

    

14. Vigorous physical activity and risk of breast cancer in the African American breast cancer epidemiology and risk consortium

    • Zhihong Gong
    • Chi-Chen Hong
    • Lynn Rosenberg

    Epidemiology 11 August 2016 Pages: 347 - 356

15. Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level

    • A. M. F. Verschoor
    • A. Kuijer
    • S. G. Elias

    Epidemiology 12 August 2016 Pages: 357 - 365

    

16. Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer

    • K. Harano
    • X. Lei
    • M. Chavez-MacGregor

    Epidemiology 13 August 2016 Pages: 367 - 374

    

17. Resting heart rate as a prognostic factor for mortality in patients with breast cancer

    • Dong Hoon Lee
    • Seho Park
    • Justin Y. Jeon

    Epidemiology 20 August 2016 Pages: 375 - 384

    

18. Reevaluation of RINT1 as a breast cancer predisposition gene

    • Na Li
    • Ella R. Thompson
    • Ian G. Campbell

    Brief Report 20 August 2016 Pages: 385 - 392

19. Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer

    • Mette S. van Ramshorst
    • Margriet van der Heiden-van der Loo
    • Gabe S. Sonke

    Erratum 17 August 2016 Pages: 393 - 393